Ibex Investors’s Immunomedics Inc IMMU Stock Holding History

Ibex Investors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15,826	Closed	-$259K	–	296
2017 Q4	$259K	Buy	+15,826	New	+$187K	0.15%	170

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ibex Investors's IMMU Position: Q1 2018 in Review

Ibex Investors sold out of Immunomedics Inc (IMMU) in Q1 2018, closing a stake of 15,826 shares — an estimated $259K sold.

Ibex Investors first reported a position in IMMU in Q4 2017 and held it in 1 quarter. The position peaked at $259K in Q4 2017. 168 funds tracked by Wall St. Rank hold IMMU as of Q1 2018.

Ibex Investors reported no remaining Immunomedics Inc position as of Q1 2018 after selling out during the quarter.
Ibex Investors sold 15,826 Immunomedics Inc shares in Q1 2018, an estimated $259K.
Ibex Investors first reported a position in Immunomedics Inc in Q4 2017 and held it in 1 quarter.
Ibex Investors's Immunomedics Inc position peaked at $259K in Q4 2017.
168 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2018.

Based on Ibex Investors's 13F filing for Q1 2018, filed 15 May 2018.